Page last updated: 2024-11-03

procarbazine and Mononeuritis

procarbazine has been researched along with Mononeuritis in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"A 12-year-old boy with Hodgkin's disease developed left peroneal nerve palsy during combination therapy with chemotherapy and low-dose irradiation."1.31Peroneal mononeuropathy in pediatric Hodgkin's disease. ( Baba, K; Harigaya, H; Matsubara, K; Nigami, H; Osaki, M, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsubara, K1
Nigami, H1
Harigaya, H1
Osaki, M1
Baba, K1

Other Studies

1 other study available for procarbazine and Mononeuritis

ArticleYear
Peroneal mononeuropathy in pediatric Hodgkin's disease.
    Leukemia & lymphoma, 2000, Volume: 40, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin Disease; Humans; Ma

2000